Key Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Key Financial's MRNA Position: Q3 2026 in Review
Key Financial held its Moderna (MRNA) position steady in Q3 2026 at 51 shares worth $9.8K. The position accounts for ﹤0.01% of the portfolio, ranked #865.
Key Financial first reported a position in MRNA in Q4 2021 and has held it in 20 quarters since. The position peaked at $108K in Q1 2023. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Key Financial held 51 shares of Moderna worth $9.8K as of Q3 2026.
- Key Financial left its Moderna share count unchanged in Q3 2026.
- Moderna made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #865 holding.
- Key Financial first reported a position in Moderna in Q4 2021 and has held it in 20 quarters since.
- Key Financial's Moderna position peaked at $108K in Q1 2023.
- 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.